LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Stanbio Expands International Distribution

By Labmedica staff writers
Posted on 14 Mar 2002
In a move to expand the distribution of its products, Stanbio Laboratory (Boerne, TX, USA) has agreed for BDS International Diagnostics Gmbh (Schwetzingen, Germany) to serve as the export sales office of Stanbio in Eastern and Western Europe, the Middle East, and the Indian subcontinent. BDS' services will include supporting and managing existing distributors and selecting and training additional distributors.

Stanbio has been producing and marketing clinical diagnostic reagents and test kits since 1960. The company's in vitro diagnostic products include clinical chemistry, serology, pregnancy, urinalysis, occult blood, microbiology, hematology, blood-grouping products, and clinical instruments. Stanbio now supplies liquid-stable and dry-powder clinical reagents as well as innovative dry-chemistry systems.

"Our product offerings will be highly attractive to the European markets, and in BDS we have a partner who shares our philosophy of quality and service,” said William R. Pippin, president of Stanbio.




Related Links:
Stanbio
BDS

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Pipette Calibration System
Artel PCS®
New
All-in-One Molecular System
AIO M160

Latest Industry News

Partnership Aims to Bring Risk-Guided CKD Care to Health Systems
14 Mar 2002  |   Industry

AI-Powered Multi-Functional Analyzer Wins German Innovation Award
14 Mar 2002  |   Industry

Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio
14 Mar 2002  |   Industry



ADLM